Publications by authors named "Hannah Woopen"

Claim this Profile
D
Development and optimization of an integrated exercise and nutrition program for ovarian cancer patients: Phase I of the BENITA multi-center study.
Tabea Maurer, Matthias H Belau, Birgit-Christiane Zyriax, Götz Welsch, Bettina Jagemann, Hannah Woopen

Gynecol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term surveillance recommendations for young adult cancer survivors.
Katharina Egger-Heidrich, Franziska Wolters, Mareike Frick, Teresa Halbsguth, Theresa Müller, Hannah Woopen

Cancer Treat Rev· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators.
Dominik Denschlag, Florian Heitz, Jacobus Pfisterer, Darja Tutschkow, Alexander Reuss, Hannah Woopen

Int J Gynecol Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexuality as a Prognostic Factor-Results of an Individual Patient Data NOGGO (North-Eastern German Society of Gynecological Oncology)-Meta-Analysis of 644 Recurrent Ovarian Cancer Patients Prior to Chemotherapy.
Nicole Balint, Hannah Woopen, Rolf Richter, Adak Pirmorady-Sehouli, Klaus Pietzner

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Creative Therapies in Gynecological Oncology: Results of a Multigenerational Survey in Patients and Caregivers.
Bettina Jantke, Jalid Sehouli, Matthias Rose, Jolijn Boer, Andreas Jantke, Hannah Woopen

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors-Results of Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey.
Hannah Woopen, Maren Keller, Dario Zocholl, Suzana Mittelstadt, Maria-Pilar Barretina-Ginesta

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Preoperative quality of life as prediction for severe postoperative complications in gynecological cancer surgery: results of a prospective study.
Jalid Sehouli, Kathrin Heise, Rolf Richter, Hannah Woopen, Louise Anders

Arch Gynecol Obstet· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ECOG and BMI as preoperative risk factors for severe postoperative complications in ovarian cancer patients: results of a prospective study (RISC-GYN-trial).
Melisa Guelhan Inci, Julia Rasch, Hannah Woopen, Kristina Mueller, Rolf Richter

Arch Gynecol Obstet· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab Combined with Platinum-Taxane Chemotherapy as First-Line Treatment for Advanced Ovarian Cancer: Results of the NOGGO Non-Interventional Study (OTILIA) in 824 Patients.
Jalid Sehouli, Alexander Mustea, Guelten Oskay-Özcelik, Maren Keller, Rolf Richter, Hannah Woopen

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis.
Joanna Baum, Elena Ioana Braicu, Oliver Hunsicker, Ignace Vergote, Nicole Concin, Hannah Woopen

Int J Gynecol Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty Index for prediction of surgical outcome in ovarian cancer: Results of a prospective study.
Melisa Guelhan Inci, Louise Anders, Hannah Woopen, Rolf Richter, Duygu Guzel

Gynecol Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary malignancies in long-term ovarian cancer survivors: results of the 'Carolin meets HANNA' study.
Hannah Woopen, Carolin Rolf, Elena Ioana Braicu, Nina Buttmann-Schweiger, Benjamin Barnes

Int J Gynecol Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Fried Frailty Score predict postoperative morbidity and mortality in gynecologic cancer surgery? Results of a prospective study.
Melisa Guelhan Inci, Louise Anders, Kathrin Heise, Rolf Richter, Hannah Woopen

J Geriatr Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative quality of life as prediction for severe postoperative complications in gynecological cancer surgery: results of a prospective study.
Jalid Sehouli, Kathrin Heise, Rolf Richter, Hannah Woopen, Louise Anders

Arch Gynecol Obstet· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of sarcopenia and malnutrition on morbidity and mortality in gynecologic cancer surgery: results of a prospective study.
Jalid Sehouli, Kristina Mueller, Rolf Richter, Markus Anker, Hannah Woopen

J Cachexia Sarcopenia Muscle· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes (PROs) and Health-Related Quality of Life (HR-QoL) in Patients with Ovarian Cancer: What Is Different Compared to Healthy Women?
Melisa Guelhan Inci, Rolf Richter, Kathrin Heise, Ricarda Dukatz, Hannah Woopen

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of predictive markers for severe postoperative complications in gynecological cancer surgery: a prospective study (RISC-Gyn Trial).
Melisa Guelhan Inci, Rolf Richter, Hannah Woopen, Julia Rasch, Kathrin Heise

Int J Gynecol Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of chemotherapy-induced nausea and vomiting in recurrent ovarian cancer patients: results of an individual participant data meta-analysis in 1213.
Hannah Woopen, R Richter, R Chekerov, G Inci, S Alavi

Support Care Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.
Jun Guan, Silvia Darb-Esfahani, Rolf Richter, Eliane T Taube, Ilary Ruscito, Hannah Woopen

J Cancer Res Clin Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphology and tumour-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survival.
Silvia Darb-Esfahani, Ivonne Kolaschinski, Fabian Trillsch, Sven Mahner, Nicole Concin, Hannah Woopen

Histopathology· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Body Mass Index (BMI) on Chemotherapy-associated Toxicity in Ovarian Cancer Patients. A Pooled Analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) Databank on 1,213 Patients.
Jacek Przemyslaw Grabowski, Rolf Richter, Hannah Rittmeister, Radoslav Chekerov, Hannah Woopen

Anticancer Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) Consortium.
Desislava Dimitrova, Ilary Ruscito, Sven Olek, Rolf Richter, Alexander Hellwag, Hannah Woopen

Tumour Biol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine Neoplasms of the Ovary: A Retrospective Study of the North Eastern German Society of Gynecologic Oncology (NOGGO).
Jalid Sehouli, Hannah Woopen, Marianne Pavel, Rolf Richter, Lisa-Kathrin Lauterbach

Anticancer Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer.
Hannah Woopen, Klaus Pietzner, Rolf Richter, Christina Fotopoulou, Thomas Joens

J Gynecol Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of epithelial cell adhesion molecule in paired tumor samples of patients with primary and recurrent serous ovarian cancer.
Klaus Pietzner, Hannah Woopen, Rolf Richter, Thomas Joens, Elena Ioana Braicu

Int J Gynecol Cancer· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis